dilazep has been researched along with DDD MPGNII in 2 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, M | 1 |
| Morozumi, K | 1 |
| Oikawa, T | 1 |
| Motokawa, M | 1 |
| Usami, T | 1 |
| Yoshida, A | 1 |
| Kimura, G | 1 |
| Tanji, C | 1 |
| Yorioka, N | 1 |
| Kanahara, K | 1 |
| Naito, T | 1 |
| Oda, H | 1 |
| Ishikawa, K | 1 |
| Taguchi, T | 1 |
1 review available for dilazep and DDD MPGNII
| Article | Year |
|---|---|
Immunotactoid glomerulopathy with microtubular deposits, with reference to the characteristics of Japanese cases.
Topics: Aged; Alprostadil; Biopsy, Needle; Blood Chemical Analysis; Blood Transfusion; Combined Modality The | 2005 |
1 other study available for dilazep and DDD MPGNII
| Article | Year |
|---|---|
Hyperimmunoglobulin E syndrome associated with nephrotic syndrome.
Topics: Adult; Anticoagulants; Biopsy; Diagnosis, Differential; Dilazep; Drug Therapy, Combination; Follow-U | 1999 |